VIA

Virtus Investment Advisers Portfolio holdings

AUM $296M
1-Year Return 31.42%
This Quarter Return
+9.26%
1 Year Return
+31.42%
3 Year Return
+126.24%
5 Year Return
–
10 Year Return
–
AUM
$296M
AUM Growth
-$72M
Cap. Flow
-$86.7M
Cap. Flow %
-29.31%
Top 10 Hldgs %
6.88%
Holding
512
New
39
Increased
197
Reduced
202
Closed
70

Top Buys

1
CEG icon
Constellation Energy
CEG
$2.01M
2
DASH icon
DoorDash
DASH
$1.82M
3
VEEV icon
Veeva Systems
VEEV
$1.75M
4
CSCO icon
Cisco
CSCO
$1.7M
5
STT icon
State Street
STT
$1.69M

Top Sells

1
VABS icon
Virtus Newfleet ABS/MBS ETF
VABS
$32.2M
2
VSHY icon
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
$24.6M
3
SEIX icon
Virtus SEIX Senior Loan ETF
SEIX
$19M
4
SMC
Summit Midstream Corporation
SMC
$3.67M
5
JNK icon
SPDR Bloomberg High Yield Bond ETF
JNK
$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNTA
326
Centessa Pharmaceuticals
CNTA
$2.11B
$103K 0.03%
7,810
-1,923
-20% -$25.3K
ABCL icon
327
AbCellera Biologics
ABCL
$1.26B
$102K 0.03%
29,852
-25,793
-46% -$88.5K
NUVB icon
328
Nuvation Bio
NUVB
$1.33B
$101K 0.03%
51,952
-10,469
-17% -$20.4K
SANA icon
329
Sana Biotechnology
SANA
$752M
$101K 0.03%
37,021
-43,446
-54% -$119K
MLTX icon
330
MoonLake Immunotherapeutics
MLTX
$3.77B
$101K 0.03%
2,136
-914
-30% -$43.1K
MBX
331
MBX Biosciences, Inc. Common Stock
MBX
$388M
$100K 0.03%
8,772
+766
+10% +$8.74K
SRRK icon
332
Scholar Rock
SRRK
$3.02B
$100K 0.03%
2,822
-1,117
-28% -$39.6K
CELC icon
333
Celcuity
CELC
$2.36B
$100K 0.03%
7,487
-5,533
-42% -$73.9K
EYPT icon
334
EyePoint Pharmaceuticals
EYPT
$966M
$99.9K 0.03%
10,613
-10,061
-49% -$94.7K
AUTL
335
Autolus Therapeutics
AUTL
$389M
$99.7K 0.03%
43,736
-17,291
-28% -$39.4K
XERS icon
336
Xeris Biopharma Holdings
XERS
$1.27B
$99.4K 0.03%
21,274
-27,014
-56% -$126K
SMMT icon
337
Summit Therapeutics
SMMT
$19.3B
$99.3K 0.03%
4,664
-4,528
-49% -$96.4K
ORIC icon
338
Oric Pharmaceuticals
ORIC
$1.06B
$98.7K 0.03%
9,724
-9,749
-50% -$99K
OLMA icon
339
Olema Pharmaceuticals
OLMA
$570M
$98.7K 0.03%
23,161
-1,266
-5% -$5.39K
VERA icon
340
Vera Therapeutics
VERA
$1.54B
$98.4K 0.03%
4,176
+539
+15% +$12.7K
SLNO icon
341
Soleno Therapeutics
SLNO
$3.71B
$98.2K 0.03%
1,172
-2,371
-67% -$199K
SLN
342
Silence Therapeutics
SLN
$269M
$97.7K 0.03%
16,837
-8,035
-32% -$46.6K
ARQT icon
343
Arcutis Biotherapeutics
ARQT
$2.06B
$97.6K 0.03%
6,965
-6,436
-48% -$90.2K
APGE icon
344
Apogee Therapeutics
APGE
$2.26B
$97.5K 0.03%
2,246
-1,455
-39% -$63.2K
ARCT icon
345
Arcturus Therapeutics
ARCT
$485M
$96.8K 0.03%
7,439
-1,914
-20% -$24.9K
PHVS icon
346
Pharvaris
PHVS
$1.48B
$96K 0.03%
5,457
-3,179
-37% -$56K
SION
347
Sionna Therapeutics, Inc. Common Stock
SION
$1.06B
$96K 0.03%
+5,535
New +$96K
ETNB icon
348
89bio
ETNB
$1.32B
$96K 0.03%
9,775
-11,137
-53% -$109K
RAPP
349
Rapport Therapeutics
RAPP
$524M
$96K 0.03%
8,441
-196
-2% -$2.23K
ELVN icon
350
Enliven Therapeutics
ELVN
$1.19B
$95.9K 0.03%
4,783
-2,359
-33% -$47.3K
12 13
14
15 16